Abstract As the coronavirus 2019 (COVID-19) pandemic marches unrelentingly, more
patients with cardiac arrhythmias are emerging due to the effects of the virus on the …

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing
in prevalence with age. AF is often associated with structural heart disease, although a …

For new or updated text, view the 2011 Focused Update and the 2011 Focused Update on
Dabigatran. Text supporting unchanged recommendations has not been updated. Atrial …

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing
in prevalence with age. AF is often associated with structural heart disease, although a …

Atrial fibrillation (AF) is the most common sustained arrhythmia and a major global public
health problem due to its associated morbidity, including stroke and heart failure, diminished …

Purpose We sought to indirectly compare and rank antiarrhythmic agents focusing
exclusively on adults with paroxysmal atrial fibrillation in order to identify the most effective …

This article reviews the safety and efficacy of ibutilide for use in patients with atrial fibrillation
and flutter. Ibutilide, a class III antiarrhythmic agent, is primarily used for conversion of atrial …

BACKGROUND: There is a need for improved approaches to rhythm control therapy of atrial
fibrillation (AF). METHODS: The effectiveness of flecainide (1.5 µmol/L) and ibutilide (20 …

New-onset atrial fibrillation (NOAF) is the most frequently encountered cardiac arrhythmia
observed in patients with COVID-19 infection, particularly in Intensive Care Unit (ICU) …

Aims Activation of beta-adrenoceptors attenuates prolongation of action potential duration
induced by blockade of the delayed rectifier potassium current. We examined whether acute …